Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial

Phlebology

Volumn 29, Issue 7, 2014, Pages 454-460

  Belczak, Sergio Q ^a   Sincos, Igor R ^a   Campos, Walter ^b   Beserra, Julio ^c   Nering, Gilberto ^c   Aun, Ricardo ^b,c  

^a Sao Camilo Medical Center   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Sao Camilo University Center   (Brazil)

Author keywords

Chronic venous insufficiency; Patient reported outcomes; Pharmacologic agents; Plethysmography; Quality of life assessment

Indexed keywords

AMINAPHTHONE; COUMARIN; COUMARIN PLUS TROXERUTIN; DAFLON; PLACEBO; SCLEROSING AGENT; TROXERUTIN; UNCLASSIFIED DRUG; 4 AMINOBENZOIC ACID DERIVATIVE; CARDIOVASCULAR AGENT; COUMARIN DERIVATIVE; DIOSMIN; HESPERIDIN; MONOXERUTIN;

ADULT; ANKLE; ARTICLE; BURNING SENSATION; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; PERIPHERAL EDEMA; PLETHYSMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT OUTCOME; URINARY TRACT INFECTION; UROLITHIASIS; VEIN DISEASE; VOMITING; ANALOGS AND DERIVATIVES; BIOMECHANICS; BRAZIL; COMPARATIVE STUDY; CONVALESCENCE; DRUG COMBINATION; DRUG EFFECTS; EDEMA; FOOT; JOINT CHARACTERISTICS AND FUNCTIONS; PATHOPHYSIOLOGY; TIME; VENOUS INSUFFICIENCY;

BIOMECHANICAL PHENOMENA; BRAZIL; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; COUMARINS; DIOSMIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EDEMA; FEMALE; FOOT JOINTS; HESPERIDIN; HUMANS; HYDROXYETHYLRUTOSIDE; MALE; PARA-AMINOBENZOATES; PLETHYSMOGRAPHY; QUALITY OF LIFE; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 84927737561     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1177/0268355513489550     Document Type: Article

References (16)

1. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997; 48: 67–69.
2. Porter JM and Moneta GL. Reporting standards in venous disease: An update. International Consensus Committee on chronic venous disease. J Vasc Surg 1995; 21: 635–45.
3. Belczak CEQ, Godoy JMP, Oliveira MA, et al. Rate of occupational leg swelling is greater in the morning than in the afternoon. Phlebology 2009; 24: 21–25.
4. Belczak CEQ, Cavalheri G, Godoy JMP, et al. Comparison of reduction of edema after rest and after muscle exercises in treatment of chronic venous insufficiency. Int Arch Med 2009; 2(1): 18.
5. Timi JR, Belczak SQ, Futigami AY, et al. Ankle ankylosis and its importance in chronic venous insufficiency. J Vasc Bras 2009; 53: 895–905.
6. PerrinMand Ramelet AA. Pharmacological treatment of primary chronic venous disease: Rationale, results and unanswered questions. Eur J Vasc Surg 2011; 41: 117–125.
7. Martinez MJ, Bonfill X, Moreno RM, et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2005; 20(3): CD003229.
8. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2012; 25(1): CD003230.
9. Coleridge Smith PD. Drug treatment of varicose veins, venous edema, and ulcers. In: Gloviczki P (ed.) Handbook of venous disorders Guidelines of the American venous Forum, 3rd ed. London: Hodder Arnold, 2009, p.359e65.
10. Nicolaides A, Allegra C, Bergan J, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Int Angiol 2008; 27: 1e59.10.
11. Ramelet AA, Boisseau MR, Allegra C, et al. Veno-active drugs in the management of chronic venous disease. An international consensus statement: Current medical position, prospective views and final resolu- tion. Clin Hemorheol Microcirc 2005; 33: 309–319.
12. Frick RW. Three treatments for chronic venous insufficiency Escin, hydroxy-ethylrutoside, and daflon. Angiology 51: 197–205.
13. Cesarone MR, Belcaro G and Rohdewald P. Comparison of Pycnogenol_ and Daflon_ in treating chronic venous insufficiency: A prospective, controlled study. Clin Appl Thrombosis/Hemostasis 2006; 12: 205–212.
14. Philip D and Coleridge Smith DM. From skin disorders to venous leg ulcers: Pathophysiology and efficacy of Daflon 500mg in ulcer healing. Angiology 2003; 54(Suppl 1): S45–S50.
15. De Anna D, Mari F, Intini S, et al. Effects of therapy with aminaftone on chronic venous and lymphatic stasis. Minerva Cardioangiol 1989; 37: 251–254.
16. Vansheidt W, Rabe E, Naser-Hijazi B, et al. the efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency A double blind placebo-controlled randomized study. Vasa 2002; 31: 185–189.